Bristol-Myers Squibb Co (NYSE: BMY)
DRUGS - Drug Manufacturers - MajorSector: Health Care
Stock price data as of 12/01/2023
Closing price: 50.10
Support price level: | N/A |
Resistance price level: | $53.63 |
Relative strength index (14-day RSI) | 47.1 |
Beta | 0.32 |
- With a -37.6 percent return in the past year, this stock is among the worst 10 percent of performers in the S&P-100.
- The price of this low-beta stock is expected to increase by 0.32% for every 1% increase in the S&P-500.
- Volatility is forecast to fall over the next month.
- Price broke below prior support level - a short-term bearish signal.
Low | High | Price as % of Range |
$48.48 | $81.13 | 6.4% |
200 day | 50 day | 20 day | 10 day |
$62.38 | $53.76 | $50.40 | $49.35 |
Historical (5 year) |
Last month | Current estimate | Next month forecast |
23.4% | 29.1% | 25.2% | 24.1% |
- 6.9% in the next week.
- 13.6% in the next month.
- 37.5% in the next year.
Company news for Bristol-Myers Squibb Co
Google Finance |
MarketWatch |
WSJ
Analysis for other Health Care stocks